Search results for "PARKINSON'S"

showing 10 items of 232 documents

Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson’s disease

2011

Camptocormia is a highly disabling syndrome that occurs in various diseases but is particularly associated with Parkinson’s disease (PD). Although first described nearly 200 years ago, the morphological changes associated with camptocormia are still under debate and the pathophysiology is unknown. We analyzed paraspinal muscle biopsies of 14 PD patients with camptocormia and compared the findings to sex-matched postmortem controls of comparable age to exclude biopsy site-specific changes. Camptocormia in PD showed a consistent lesion pattern composed of myopathic changes with type-1 fiber hypertrophy, loss of type-2 fibers, loss of oxidative enzyme activity, and acid phosphatase reactivity …

MalePathologymedicine.medical_specialtyParkinson's diseaseMyopathyClinical Neurology610BiologySpinal CurvaturesMuscle hypertrophyPathology and Forensic MedicineLesionMuscular Atrophy Spinal03 medical and health sciencesCamptocormiaMyofibrillar disorganizationCellular and Molecular Neuroscience0302 clinical medicineMyofibrilsBiopsymedicineHumansProspective StudiesMyopathyMuscle SkeletalParkinson’s disease; Camptocormia; Myopathy; Myofibrillar disorganization; ProprioceptionMyositis030304 developmental biologyAgedAged 80 and over0303 health sciencesOriginal Papermedicine.diagnostic_testParkinson DiseaseMiddle Agedmedicine.diseaseProprioceptionPathophysiologyCamptocormiaParkinson’s diseaseFemaleNeurology (clinical)medicine.symptomMedicine & Public Health; Neurosciences; Pathology030217 neurology & neurosurgeryActa Neuropathologica
researchProduct

Sleep quality in caregivers of patients with Alzheimer’s disease and Parkinson’s disease and its relationship to quality of life

2012

ABSTRACTBackground: Knowledge about sleep complaints of caregivers of patients with Alzheimer's disease (AD) and Parkinson's disease (PD) is limited, and we lack information about the relationship between caregivers’ sleep problems and their quality of life (QoL).Methods: We evaluated subjective sleep quality and its relationship to QoL in a group of 80 caregivers of patients with AD (ADCG, n = 40) and PD (PDCG, n = 40), and in 150 controls. Information about night-time complaints was collected using the Pittsburgh Sleep Quality Index (PSQI). QoL was measured using the McGill QoL Questionnaire.Results: Eighteen ADCG (45%), 22 PDCG (55%), and 45 (30%) controls reported poor sleep quality. Me…

MaleSleep Wake DisordersCoping (psychology)medicine.medical_specialtyParkinson's diseaseDiseaseSleep Wake DisordersSeverity of Illness IndexPittsburgh Sleep Quality IndexCost of IllnessAlzheimer DiseaseSickness Impact ProfileSurveys and QuestionnairesSeverity of illnessMedicineHumansAgedAged 80 and overAlzheimer’s disease Parkinson’s disease neurodegenerative disorders caregivers sleep depression quality of lifebusiness.industryDepressionParkinson DiseaseMiddle Agedmedicine.diseasePsychiatry and Mental healthClinical PsychologySleep deprivationCaregiversItalyPhysical therapyQuality of LifeRegression AnalysisSleep DeprivationFemaleSettore MED/26 - NeurologiaSelf ReportGeriatrics and Gerontologymedicine.symptomAlzheimer's diseasebusinessGerontologyStress Psychological
researchProduct

The effects of transdermal rotigotine on non-motor symptoms of Parkinson's disease: a multicentre, observational, retrospective, post-marketing study

2017

This study evaluated the effect of ≥6 months of transdermal rotigotine on non-motor and motor symptoms of patients with advanced Parkinson's disease.The study was conducted in Spain between September 2011 and December 2012 (ClinicalTrials.gov: NCT01504529). The primary efficacy variable was the change from baseline in non-motor symptoms, as assessed by changes in Parkinson's Disease Non-Motor Symptoms Questionnaire total scores at 6 months. Secondary endpoints included the assessment of motor symptoms by Unified Parkinson's Disease Rating Scale III scores.Data from 378 patients (mean age: 70.2 years; 56.9% male) with Parkinson's disease receiving rotigotine from were collected. Mean disease…

MaleSleep Wake Disordersmedicine.medical_specialtyParkinson's diseaseTetrahydronaphthalenesThiophenesDiseaseAdministration CutaneousMotor symptoms03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesProduct Surveillance PostmarketingmedicineHumans030212 general & internal medicineAgedRetrospective StudiesTransdermalAged 80 and overbusiness.industryGeneral NeuroscienceParkinson DiseaseRotigotineGeneral MedicineUrination Disordersmedicine.diseaseClinical PracticeTreatment OutcomeSpainDopamine AgonistsPhysical therapyNon motorFemaleObservational studyCognition Disordersbusiness030217 neurology & neurosurgerymedicine.drugInternational Journal of Neuroscience
researchProduct

The Role of Recollection and Familiarity in Nondemented Parkinson's Patients

2017

The aim of the current study was to examine if recollection and familiarity decline in nondemented Parkinson's patients. To do so we compared a sample of older people with Parkinson's disease (n = 32) to a control sample of healthy older people (n = 32) on an associative recognition task in which we manipulated the repetition of the pairs during the study phase (half of the pairs were presented once and half twice) to obtain corrected estimates of recollection, familiarity, and false recognition based on the logic of the process-dissociation procedure. The results clearly show that recollection is impaired but familiarity is preserved in nondemented Parkinson's patients. The results show th…

MaleStudy phaseParkinson's diseaseExperimental and Cognitive PsychologyNeuropsychological Tests050105 experimental psychologyGender Studies03 medical and health sciences0302 clinical medicineArts and Humanities (miscellaneous)medicineHumans0501 psychology and cognitive sciencesControl sampleAgedAged 80 and overRecall05 social sciencesParkinson DiseaseRecognition PsychologyMiddle Agedmedicine.diseaseFalse recognitionMental RecallFemaleOlder peoplePsychology030217 neurology & neurosurgeryCognitive psychologyThe Journal of General Psychology
researchProduct

Autobiographical memory in Parkinson's disease: A retrieval deficit

2012

This study examined the effects of providing cues to facilitate autobiographical memory retrieval in Parkinson's disease. Previous findings have shown that individuals with Parkinson's disease retrieve fewer specific autobiographical memories than older adult controls. These findings are clinically significant since the quality of autobiographical memory is linked to identity and sense of self. In the current study, 16 older adults with Parkinson's disease without dementia and 16 matched older adult controls were given 3 min in which to recall autobiographical memories associated with five different time periods and to give each memory a short title. Participants were later asked to retriev…

MaleTime FactorsParkinson's diseaseRecallAutobiographical memoryMemory EpisodicCognitive NeuroscienceNeuropsychologyParkinson Diseasemedicine.diseaseBehavioral NeuroscienceNeuropsychology and Physiological PsychologyFree recallCase-Control StudiesMental RecallmedicineHumansDementiaFemaleChildhood memoryCuesPsychologyEpisodic memoryAgedCognitive psychologyJournal of Neuropsychology
researchProduct

Impaired reproduction of second but not millisecond time intervals in Parkinson's disease

2008

The basal ganglia have been associated with temporal processing in ranges of milliseconds and seconds. However, results from PD patient studies are elusive. Time perception in these patients has been tested with different approaches including repetitive movement tasks (i.e. finger tapping) and cognitive tasks (i.e. time reproduction), and both abnormal and normal performances have been reported for different time intervals. Furthermore, when PD patients were required to learn two target durations in the same session when they were off medication, they overestimated the short duration and underestimated the long duration in the seconds range. This pattern of temporal accuracy was described a…

MaleTime perception; Parkinson's disease; Basal ganglia; Dopamine; MemoryParkinson's diseaseDopamineNeuropsychological TestsAudiologyBehavioral neuroscienceAntiparkinson AgentsBehavioral NeuroscienceCognitionAttentionBRAINTomographyDepression; Humans; Tomography X-Ray Computed; Time Perception; Aged; Antiparkinson Agents; Memory Disorders; Cognition; Psychiatric Status Rating Scales; Parkinson Disease; Psychomotor Performance; Middle Aged; Neuropsychological Tests; Attention; Female; Male; Reaction TimeMillisecondDepressionParkinson DiseaseCognitionPsychiatric Status Rating ScaleMiddle AgedTime perceptionTIMEX-Ray ComputedNeuropsychology and Physiological PsychologyAntiparkinson AgentBasal gangliaNeuropsychological TestFemaleSettore MED/26 - NeurologiaPsychologyHumanMemory Disordermedicine.medical_specialtyElementary cognitive taskCognitive NeuroscienceExperimental and Cognitive PsychologyCognitive neuroscienceNOMemoryReaction TimemedicineHumansAgedPsychiatric Status Rating ScalesMemory DisordersSettore M-PSI/02 - Psicobiologia E Psicologia FisiologicaMemoriaTime PerceptionFinger tappingTomography X-Ray ComputedPARKINSONNeurosciencePsychomotor PerformanceNeuropsychologia
researchProduct

Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model?

2010

It has been recently shown that the substantia nigra pars reticulata (SNr) of 6-hydroxydopamine (6-OHDA)-lesioned rats, under urethane anaesthesia, manifests a prominent low frequency oscillation (LFO) of around 1Hz, synchronized with cortical slow wave activity (SWA). Nevertheless, it is poorly understood whether these electrophysiological alterations are correlated only with severe dopamine depletion or may also play a relevant pathogenetic role in the early stages of the dopamine denervation. Hence, here we recorded SNr single units and electrocorticogram (ECoG) in two models of dopamine denervation: (i) acute dopamine denervated rats, obtained by injection of tetrodotoxin (TTX), (ii) ch…

MaleTyrosine 3-Monooxygenasebasal ganglia oscillationsDopamineParkinson's diseaseWistarAction PotentialsParkinson's disease; Low frequency oscillation basal ganglia oscillations; Medial forebrain bundle; Tetrodotoxin; ElectrocorticogramTetrodotoxinSettore BIO/09 - FisiologiaParkinson's disease; low frequency oscillation; basal ganglia oscillations; medial forebrain bundle; Tetrodotoxin; electrocorticogramStatistics NonparametricAnimals; Analysis of Variance; Action Potentials; Electrophysiology; Tyrosine 3-Monooxygenase; Cerebral Cortex; Rats; Biological Clocks; Dopamine; Neurons; Rats Wistar; Substantia Nigra; Immunohistochemistry; Medial Forebrain Bundle; Statistics Nonparametric; MaleMedial forebrain bundlechemistry.chemical_compoundDevelopmental NeuroscienceBiological ClocksDopamineBasal gangliamedicineAnimalsNonparametricRats WistarMedial forebrain bundleElectrocorticographyCerebral CortexNeuronsDenervationAnalysis of Variancemedicine.diagnostic_testChemistryStatisticsLow frequency oscillation basal ganglia oscillationElectrocorticogramImmunohistochemistryRatsCortex (botany)ElectrophysiologySubstantia NigraElectrophysiologynervous systemNeurologylow frequency oscillationTetrodotoxinSettore MED/26 - NeurologiaNeurosciencemedicine.drug
researchProduct

In patient’s with Parkinson disease, autonomic symptoms are frequent and associated with other non-motor symptoms

2015

Background: Autonomic symptoms and sleep disorders are common non-motor symptoms of Parkinson disease (PD), which are correlated with poor quality of life for patients. Purpose: To assess the frequency of autonomic symptoms in a consecutive series of PD patients and to correlate them with other motor and non-motor symptoms. Methods: All consecutive non-demented PD patients who underwent an extensive evaluation including Hoehn and Yahr staging, Unified Parkinson’s Disease Rating Scale, Beck’s Depression Inventory, Neuropsychiatric Inventory, PDQ-39 Scale, the Parkinson’s diseases Sleep Scale, the Epworth Sleepiness Scale and SCOPA-AUT scale were enrolled. Comorbidity has been also considered…

Malemedicine.medical_specialtyLevodopaNeurologyParkinson's diseaseDiseaseAutonomic symptomNon-motor symptomRating scaleInternal medicinemedicineHumansDepression (differential diagnoses)AgedEndocrine and Autonomic Systemsbusiness.industryEpworth Sleepiness ScaleParkinson DiseaseSleep disordersMiddle Agedmedicine.diseaseComorbidityCross-Sectional StudiesAutonomic Nervous System DiseasesParkinson’s diseaseFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessmedicine.drug
researchProduct

Effects of progressive resistance exercise in akinetic-rigid Parkinson's disease patients: a randomized controlled trial.

2017

Progressive resistance exercise (PRE) can have a positive effect in individuals with Parkinson’s disease (PD). However, the effect of PRE may vary with the clinical subtype of PD. To date, no study has assessed the effects of PRE in the different subtypes of PD. AIM: The aim of the present study was to assess the effects of PRE in PD patients with akinesia and rigidity (AR-subtype). DESIGN: A randomized controlled trial was conducted. SETTING: Outpatients clinics of the Bierzo Parkinson Association (Ponferrada, Spain) and the Asturias Parkinson Association (Oviedo, Spain). POPULATION: Twenty-eight patients with AR-subtype PD were randomized into an Experimental Group (EG, N.=13) and Control…

Malemedicine.medical_specialtyMovement disordersParkinson's diseasemedicine.medical_treatmentCondición física - EjerciciosPopulationEnfermedad del sistema nerviosoPhysical Therapy Sports Therapy and RehabilitationRisk Assessmentlaw.invention03 medical and health sciencesTratamiento médico0302 clinical medicineRhythmPhysical medicine and rehabilitationRandomized controlled triallawRating scaleReference ValuesMedicineHumans030212 general & internal medicineeducationGaitPostural BalanceAgededucation.field_of_studyRehabilitationbusiness.industryRehabilitationPosturographyParkinson DiseaseResistance TrainingDeporteMiddle Agedmedicine.diseaseExercise TherapyTreatment OutcomeEnfermedad de ParkinsonSpainPhysical therapyParkinson’s diseaseFemalemedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up StudiesEuropean journal of physical and rehabilitation medicine
researchProduct

The neuropsychiatric profile of Parkinson's disease subjects with and without mild cognitive impairment

2012

Neuropsychiatric symptoms (NPS) are common clinical features of Parkinson's disease (PD). However, NPS profiles in PD subjects with mild cognitive impairment (MCI) have scarcely been investigated. We aimed to describe the NPS profiles of non-demented PD subjects with and without MCI. A total of 410 non-demented PD subjects were included. Of these, 164 were cognitively normal PD subjects (PD-cn), 142 PD had amnestic MCI (PD-aMCI), and 104 had PD with non-amnestic MCI (PD-naMCI). NPS were evaluated in accordance with the Neuropsychiatric Inventory (NPI). PD-aMCI subjects revealed the highest NPS burden, followed by PD-naMCI and then PD-cn. Overall, the most common NPS in PD-MCI were in order:…

Malemedicine.medical_specialtyNeurologyParkinson's diseaseNeuropsychological TestsIrritabilitySeverity of Illness Indexbehavioral disciplines and activitiesCognitionInternal medicinemental disordersSeverity of illnessmedicineHumansCognitive DysfunctionApathyParkinson’s disease Cognitive impairment Neuropsychiatric symptoms EpidemiologyBiological PsychiatryDepression (differential diagnoses)AgedSleep disordertechnology industry and agricultureParkinson DiseaseMiddle Agedmedicine.diseasePsychiatry and Mental healthNeurologyPhysical therapyAnxietyFemaleSettore MED/26 - NeurologiaAmnesiaNeurology (clinical)medicine.symptomPsychology
researchProduct